Compare LFST & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LFST | RXRX |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 2021 | 2021 |
| Metric | LFST | RXRX |
|---|---|---|
| Price | $6.94 | $3.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $9.83 | $7.50 |
| AVG Volume (30 Days) | 1.5M | ★ 10.8M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,424,285,000.00 | $74,681,000.00 |
| Revenue This Year | $17.18 | $12.11 |
| Revenue Next Year | $14.02 | $82.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 13.85 | ★ 26.92 |
| 52 Week Low | $3.74 | $2.80 |
| 52 Week High | $8.09 | $7.18 |
| Indicator | LFST | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 62.65 | 59.62 |
| Support Level | $6.75 | $2.89 |
| Resistance Level | $7.33 | $4.08 |
| Average True Range (ATR) | 0.17 | 0.17 |
| MACD | 0.08 | 0.08 |
| Stochastic Oscillator | 93.51 | 79.00 |
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.